These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
851 related articles for article (PubMed ID: 21900882)
1. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Devi L; Ohno M Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882 [TBL] [Abstract][Full Text] [Related]
2. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice. Devi L; Ohno M Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043 [TBL] [Abstract][Full Text] [Related]
3. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
4. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L; Ohno M Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558 [TBL] [Abstract][Full Text] [Related]
5. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Devi L; Ohno M Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928 [TBL] [Abstract][Full Text] [Related]
6. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. Devi L; Ohno M PLoS One; 2010 Sep; 5(9):e12974. PubMed ID: 20886088 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710 [TBL] [Abstract][Full Text] [Related]
8. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease. Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression. Devi L; Tang J; Ohno M Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425 [TBL] [Abstract][Full Text] [Related]
11. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Sadleir KR; Eimer WA; Cole SL; Vassar R Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease. Devi L; Ohno M Transl Psychiatry; 2013 Jul; 3(7):e284. PubMed ID: 23880880 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Devi L; Ohno M Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711 [TBL] [Abstract][Full Text] [Related]
14. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice. Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027 [TBL] [Abstract][Full Text] [Related]
15. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages. Devi L; Ohno M Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636 [TBL] [Abstract][Full Text] [Related]
16. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease. Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331 [TBL] [Abstract][Full Text] [Related]
17. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS. Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412 [TBL] [Abstract][Full Text] [Related]
18. 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease. Zhang Z; Liu X; Schroeder JP; Chan CB; Song M; Yu SP; Weinshenker D; Ye K Neuropsychopharmacology; 2014 Feb; 39(3):638-50. PubMed ID: 24022672 [TBL] [Abstract][Full Text] [Related]
19. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity. Hook G; Hook V; Kindy M J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740 [TBL] [Abstract][Full Text] [Related]
20. Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice. Kim N; Do J; Ju IG; Jeon SH; Lee JK; Oh MS Neurotherapeutics; 2020 Jan; 17(1):189-199. PubMed ID: 31741224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]